Berikutnya

Putar otomatis

Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman

4 Tampilan • 07/30/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis